NKEIRU UWAZIE: Open Payments
NPI 1952670291 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 25 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $185 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| Lundbeck LLC | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 4 | $89 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $26 |
Products named: ABILIFY MAINTENA, INVEGA SUSTENNA, UZEDY, INGREZZA, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
